Yahoo Malaysia Web Search

Sign In

Search results

  1. www.reuters.com › business › healthcare-pharmaceuticalsAbbVie cuts 2024 profit forecast on R&D expenses | Reuters

    3 days ago · AbbVie lowered its 2024 adjusted profit forecast on Wednesday, citing $937 million in milestones, and research and development expenses related to acquisitions.

  2. sg.finance.yahoo.com › news › 72-ownership-abbvie-inc-nyseWith 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong ...

    5 days ago · Significantly high institutional ownership implies AbbVie's stock price is sensitive to their trading actions The top 25 shareholders own 46% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company To get a sense of who ...

  3. seekingalpha.com › article › 4702460-abbvie-upgraded-to-a-buyAbbVie Q2 Preview: Upgrade To Buy - Better Late Than Never

    2 days ago · This is because ABBV continues to report robust ex-Humira portfolio growth at +15% YoY in FQ1'24 while guiding robust FQ2'24 revenues of $14B (+0.9% YoY) and adj EPS of $3.07 (+5.4% YoY) at the ...

  4. pharmaphorum.com › news › abbvie-licenses-futuregen-ibd-drugAbbVie licenses FutureGen IBD drug in $1.7bn deal

    3 days ago · AbbVie is paying $150 million upfront for rights to Chinese biotech FutureGen Biopharmaceutical’s FG-M701, described as a next-generation antibody that binds to tumour necrosis factor-like...

  5. news.abbvie.com › 2024/07/02-AbbVie-to-Host-Second-QuarterAbbVie to Host Second-Quarter 2024 Earnings Conference Call

    5 days ago · NORTH CHICAGO, Ill., July 2, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) will announce its second-quarter 2024 financial results on Thursday, July 25, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time.

  6. pharmaphorum.com › a-history-of-abbott-and-abbvieA history of Abbott and AbbVie | pharmaphorum

    4 days ago · This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old man...

  7. markets.ft.com › data › equitiesAbbVie Inc, ABBV:NYQ summary - FT.com - Financial Times

    4 days ago · Latest AbbVie Inc (ABBV:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.